---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-053769"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2025-04-14T23:59:59+00:00"
generated_at: "2026-05-23T15:35:59.818709+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Tivic Health adds $1.77M baby shelf capacity under existing Equity Distribution Agreement

## Summary
- Company may sell up to $1,767,913 in common stock through Maxim Group under updated prospectus supplement.
- Sales are under existing $10M Equity Distribution Agreement dated Sept 2024, subject to Form S-3 baby shelf limit.
- Legal opinion of Snell & Wilmer L.L.P. regarding the shares filed as Exhibit 5.1.

## SEC filing metadata
- accession: 0000950170-25-053769
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2025-04-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017025053769/0000950170-25-053769-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017025053769/tivc-20250414.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-053769
- JSON: https://secwatch.observer/filing/0000950170-25-053769.json
- Plain text: https://secwatch.observer/filing/0000950170-25-053769.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.